PWE-075
| Placebo (N=645) | PRU 2 mg (N=640) | PRU 4 mg (N=639) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | Cum % | n | % | Cum % | n | % | Cum % | |
| ≥3 SCBM/week | 73 | 11.3 | 11.3 | 151 | 23.6 | 23.6 | 158 | 24.7 | 24.7 |
| Increase avg SCBM ≥1 | 82 | 12.7 | 24.0 | 115 | 18.0 | 41.6 | 124 | 19.4 | 44.1 |
| Impr ≥1 Satisfaction | 54 | 8.4 | 32.4 | 92 | 14.4 | 55.9 | 92 | 14.4 | 58.5 |
| Increase avg SBM ≥1 | 106 | 16.4 | 48.8 | 109 | 17.0 | 73.0 | 103 | 16.1 | 74.6 |
| Increase avg BM ≥1 | 64 | 9.9 | 58.8 | 31 | 4.8 | 77.8 | 35 | 5.5 | 80.1 |